Home

Johann Pourcelot Photographie

Methodology and Quality of Life Unit in Oncology

Our group is dedicated to methodological expertise in the field of clinical trials and epidemiological studies by using the latest validated and meaningful strategies. Our philosophy is to bridge the gap between requirement for an optimal clinical research and benefit for the patient. Consequently, we develop research in quality of life, endpoints and outcomes, clinical trial designs and scoring systems used to help for clinical management of patients and to design future clinical trials. Our international and national collaborations allow us to disseminate our research philosophy and our expertise. The about 20 oncologists, CRA, data managers, statisticians and epidemiologists of the team all together promote in their expertise the idea that the interest of patient should be the key component to guide our research: “Cancer is not only a tumor”.

Learn more about
Methodology and Quality of Life Unit in Oncology

Our group is dedicated to methodological expertise in the field of clinical trials and epidemiological studies by using the latest validated and meaningful strategies. Our philosophy is to bridge the gap between requirement for an optimal clinical research and benefit for the patient. Consequently, we develop research in quality of life, endpoints and outcomes, clinical trial designs and scoring systems used to help for clinical management of patients and to design future clinical trials. Our international and national collaborations allow us to disseminate our research philosophy and our expertise. The about 20 oncologists, CRA, data managers, statisticians and epidemiologists of the team all together promote in their expertise the idea that the interest of patient should be the key component to guide our research: “Cancer is not only a tumor”.

Learn more about
Methodology and Quality of Life Unit in Oncology

Our group is dedicated to methodological expertise in the field of clinical trials and epidemiological studies by using the latest validated and meaningful strategies. Our philosophy is to bridge the gap between requirement for an optimal clinical research and benefit for the patient. Consequently, we develop research in quality of life, endpoints and outcomes, clinical trial designs and scoring systems used to help for clinical management of patients and to design future clinical trials. Our international and national collaborations allow us to disseminate our research philosophy and our expertise. The about 20 oncologists, CRA, data managers, statisticians and epidemiologists of the team all together promote in their expertise the idea that the interest of patient should be the key component to guide our research: “Cancer is not only a tumor”.

Learn more about

Latest News

UMQVC was at EPICLIN

Saturday, May 18 2019

Someof the team's work was presented at the EPICLIN congress, the 13th FrancophoneConference of Clinical Epidemiology...

Posted by: Dr. Sophie PAGET-BAILLY
Pictures from the ESMO congress

Monday, October 29 2018

A The research considering Postoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin...

Posted by: Dr. Dewi VERNEREY
Meet our team at the ESMO congress

Monday, September 10 2018

20.10.2018 – HALL A3 – Poster area12:30 - 94P - HPV circulating tumor DNA as predictive biomarker of sustained...

Posted by: Dr. Sophie PAGET-BAILLY
Meet our team at the ISOQOL congress

Monday, September 10 2018

Oral presentation by Emilie CHARTON, the 26th of October at 2PM, during the session Clinical trials methods:Time to...

Posted by: Dr. Sophie PAGET-BAILLY
Award ceremony for the "Franck Bonnetain prize" at EPICLIN

Wednesday, June 13 2018

The "Franck BONNETAIN" prize of € 1000 for an oral communication on the theme of cancer was awarded during the EPICLIN...

Posted by: Dr. Sophie PAGET-BAILLY
Our team is at ASCO annual meeting

Wednesday, May 30 2018

Oral communicationLundi 4 juin – 9:24-9:36 – HALL B1MAPS Impact on health-related quality of life of the addition of...

Posted by: Dr. Sophie PAGET-BAILLY
Our team is at EPICLIN

Tuesday, May 29 2018

Our team is at the congress of French speaking researchers and professional of clinical epidemiology and biostatistics,...

Posted by: Dr. Sophie PAGET-BAILLY
2nd class 3 of Lycée Carnot (Dijon) donates to the UMQVC

Thursday, April 26 2018

As part of the "citizen journey" organized by the Lycée Carnot (Dijon), the students of class of seconds were invited...

Posted by: Dr. Sophie PAGET-BAILLY
Award at JFHOD 2018 for best oral communication in the session Cancers - others

Friday, April 13 2018

Winning collaboration between Cindy Neuzillet (Gastroenterologist) and Dewi Vernerey (Methodologist)Prédiction de la...

Posted by: Dr. Dewi VERNEREY
The Lung Cancer Group is looking for an author of systematic reviews in English language

Monday, April 09 2018

The Cochrane Lung Cancer Group, based in Besancon and with which the UMQVC collaborates, is looking for an author of...

Posted by: Dr. Sophie PAGET-BAILLY

Latest publications

HPV16 Load Is a Potential Biomarker to Predict Risk of High-Grade Cervical Lesions in High-Risk HPV-Infected Women: A Large Longitudinal French Hospital-Based Cohort Study

AbstractHigh-risk HPV (hrHPV) testing has been implemented as a primary screening tool for cervical cancer in numerous...

Posted by : Mme. Julie HENRIQUES, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY
Journal name : Cancers (Basel)

Metastatic colorectal carcinoma with signet-ring cells: Clinical, histological and molecular description from an Association des Gastro-Entérologues Oncologues (AGEO) French multicenter retrospective cohort

AbstractBackground: Metastatic signet-ring cell colorectal carcinoma is rare. We analyzed its clinicopathological...

Posted by : Mme. Astrid POZET, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Dig Liver Dis

Impact of open-label versus blinded study design on patient-reported outcomes data in randomized clinical trials of immunotherapy in advanced or metastatic cancer patients: a systematic review

AbstractAim: A systematic literature review of immuno-oncology trials was conducted to assess the potential impact...

Posted by : Mme. Astrid POZET, Mr. Antoine FALCOZ, Dr. Guillaume MOUILLET
Journal name : Qual Life Res

Team members

Franck BONNETAIN

Pr. Franck BONNETAIN

 Epidemiologist / Statistician, PhD / Professor, Head of UMQVC

University Hospital of Besançon

franck.bonnetain@univ-fcomte.fr

 Linkedin profile
Researchgate profile
Oumelkheir DJOUMAKH

Oumelkheir DJOUMAKH

 Data manager - UMQVC

CHRU Besançon

oekdjoumakh@chu-besançon.fr

 Linkedin profile
Antoine FALCOZ

Antoine FALCOZ

 Statistician - Clinical Research Engineer - UMQVC

CHRU Besançon

afalcoz@chu-besancon.fr

 Linkedin profile
Joëlle FRITZSCH

Joëlle FRITZSCH

 Clinical research asociate

University hospital of Besançon

jfritzsch@chu-besancon.fr
Julie HENRIQUES

Julie HENRIQUES

 Statistician

Clinical Research Engineer at UMQVC

jhenriques@chu-besancon.fr

 Linkedin profile
Researchgate profile
Aurélia MEURISSE

Aurélia MEURISSE

 Data-manager - UMQVC

University Hospital of Besançon

ahusse@chu-besancon.fr

 Linkedin profile
Researchgate profile
Guillaume MOUILLET

Dr. Guillaume MOUILLET

 Medical Doctor, Medical Oncology, IRFC-FC, University Hospital of Besançon - Epidemiologist at UMQVC

University Hospital of Besançon

gmouillet@chu-besancon.fr
Sophie PAGET-BAILLY

Dr. Sophie PAGET-BAILLY

 Epidemiologist, PhD - Clinical Research Engineer at UMQVC

University Hospital of Besançon

spaget@chu-besancon.fr

 Linkedin profile
Researchgate profile
Related Files :
CV english S Paget-Bailly.pdf
PhD S Paget-Bailly.pdf
Astrid POZET

Astrid POZET

 Epidemiologist - UMQVC

University Hospital of Besançon

apozet@chu-besancon.fr

 Linkedin profile
Researchgate profile
Dewi VERNEREY

Dr. Dewi VERNEREY

 Senior Hospital Engineer | Epidemiologist – Statistician

Head of the “Epidemiology and Biostatistics” module

dvernerey@chu-besancon.fr

 Linkedin profile
Researchgate profile
Related Files :
CV_D_Vernerey_17_01_2018.pdf
PhD_D_Vernerey.pdf
Angélique VIENOT

Dr. Angélique VIENOT

 Gastroenterologist

University Hospital of Besançon

angelique.vienot@gmail.com

↑

Website by Pearlweb

Team members

Franck BONNETAIN

 Epidemiologist / Statistician, PhD / Professor, Head of UMQVC University Hospital of Besançon

Oumelkheir DJOUMAKH

 Data manager - UMQVC CHRU Besançon

Antoine FALCOZ

 Statistician - Clinical Research Engineer - UMQVC CHRU Besançon

Joëlle FRITZSCH

 Clinical research asociate University hospital of Besançon

Julie HENRIQUES

 Statistician Clinical Research Engineer at UMQVC

Aurélia MEURISSE

 Data-manager - UMQVC University Hospital of Besançon

Guillaume MOUILLET

 Medical Doctor, Medical Oncology, IRFC-FC, University Hospital of Besançon - Epidemiologist at UMQVC University Hospital of Besançon

Sophie PAGET-BAILLY

 Epidemiologist, PhD - Clinical Research Engineer at UMQVC University Hospital of Besançon

Astrid POZET

 Epidemiologist - UMQVC University Hospital of Besançon

Dewi VERNEREY

 Senior Hospital Engineer | Epidemiologist – Statistician Head of the “Epidemiology and Biostatistics” module

Angélique VIENOT

 Gastroenterologist University Hospital of Besançon

 Epidemiologist / Statistician, PhD / Professor, Head of UMQVC

University Hospital of Besançon

 Data manager - UMQVC

CHRU Besançon

 Statistician - Clinical Research Engineer - UMQVC

CHRU Besançon

 Clinical research asociate

University hospital of Besançon

 Statistician

Clinical Research Engineer at UMQVC

 Data-manager - UMQVC

University Hospital of Besançon

 Medical Doctor, Medical Oncology, IRFC-FC, University Hospital of Besançon - Epidemiologist at UMQVC

University Hospital of Besançon

 Epidemiologist, PhD - Clinical Research Engineer at UMQVC

University Hospital of Besançon

 Epidemiologist - UMQVC

University Hospital of Besançon

 Senior Hospital Engineer | Epidemiologist – Statistician

Head of the “Epidemiology and Biostatistics” module

 Gastroenterologist

University Hospital of Besançon